Medical Research News

RSS

Study demonstrates efficacy of canakinumab at tapering corticosteroid use in patients with SJIA

Study findings first presented today at EULAR 2013, the Annual Congress of the European League Against Rheumatism, demonstrate the efficacy of canakinumab at tapering corticosteroid (CS) use in patients with SJIA.

14 Jun 2013

New drug target may prevent consequences of ACL tear in athletes

Striking the likes of Chicago Bulls' Derrick Rose, L.A. Lakers' Kobe Bryant and Detroit Tigers' Victor Martinez, tears in the anterior cruciate ligament (ACL) are one of the most rampant and serious knee injuries among athletes.

14 Jun 2013

Study: Certified bicycle helmets reduce causes of injury and impact force of crash

Sydney: A laboratory study has found that bicycle helmets certified to Australia's national standard significantly reduce the causes of head, skull and brain injury - linear and angular head accelerations, and the impact force of a crash.

14 Jun 2013

Farmworkers continue to experience excessive heat even after leaving the fields, shows research

Hot weather may be the work environment for the 1.4 million farmworkers in the United States who harvest crops, but new research shows that these workers continue to experience excessive heat and humidity even after leaving the fields.

14 Jun 2013

Study suggests promising brain-imaging technique to improve diagnoses of people with movement disorders

A new University of Florida study suggests a promising brain-imaging technique has the potential to improve diagnoses for the millions of people with movement disorders such as Parkinson's disease.

14 Jun 2013

CSHL scientists solve the mystery of why some infants born with grave syndrome

By identifying a protein that acts as a genetic modifier, scientists at Cold Spring Harbor Laboratory have solved the mystery of why some infants are born with a grave syndrome consisting of cleft palate and major deformities of the skin and limbs, while other infants bearing the same predisposing genetic mutation bear little or no sign of the illness, called EEC.

14 Jun 2013

Research: Older adults who volunteer for work decrease their risk of hypertension

New research from Carnegie Mellon University shows that older adults who volunteer for at least 200 hours per year decrease their risk of hypertension, or high blood pressure, by 40 percent.

14 Jun 2013

EULAR announces recipients of Meritorious Service Award

EULAR today announced the recipients of the 13th annual Meritorious Service Award at the opening of the European League Against Rheumatism Annual Congress.

14 Jun 2013

Overweight, obese ERA patients require twice as much drug therapy to achieve successful remission

A new study presented today at EULAR 2013, the Annual Congress of the European League Against Rheumatism, shows that overweight and obese patients are less likely to achieve successful remission in early rheumatoid arthritis compared to those of normal weight.

14 Jun 2013

Study offers hope for development of novel treatments for stroke, neurological diseases

A specific MicroRNA, a short set of RNA (ribonuclease) sequences, naturally packaged into minute (50 nanometers) lipid containers called exosomes, are released by stem cells after a stroke and contribute to better neurological recovery according to a new animal study by Henry Ford Hospital researchers.

14 Jun 2013

Ischaemic heart disease patients at risk after 1 week of treatment

New study data presented today at EULAR 2013, the Annual Congress of the European League Against Rheumatism, demonstrate a high prevalence of NSAID prescriptions in patients at risk of ischaemic heart disease.

14 Jun 2013

Novel antibody biomarkers could significantly improve diagnosis in RA, study shows

Data presented at EULAR 2013, the Annual Congress of the European League Against Rheumatism, show that novel antibody biomarkers could significantly improve diagnosis in rheumatoid arthritis.

14 Jun 2013

Findings provide basis for reinvigoration of research efforts in breast cancer prevention

Genetic variations, known as single nucleotide polymorphisms, in or near the genes ZNF423 and CTSO were associated with breast cancer risk among women who underwent prevention therapy with tamoxifen and raloxifene, according to data published in Cancer Discovery, a journal of the American Association for Cancer Research.

14 Jun 2013

Qiaobing Xu selected as Pew Scholar in Biomedical Sciences

Qiaobing Xu, assistant professor of biomedical engineering at Tufts University School of Engineering, was named a Pew Scholar in Biomedical Sciences by the Pew Charitable Trusts.

14 Jun 2013

Pew Charitable Trusts selects NYU professor as Pew Scholar in Biomedical Sciences

Fei Li, an assistant professor in New York University's Department of Biology, has been selected as a Pew Scholar in the Biomedical Sciences by The Pew Charitable Trusts.

14 Jun 2013

Finasteride has ability to modulate alcohol intake, finds GW researcher

Researcher Michael S. Irwig, M.D., F.A.C.E., assistant professor of medicine at the George Washington University School of Medicine and Health Sciences and director of the Center for Andrology at The GW Medical Faculty Associates, found that men who used the medication finasteride (Propecia) and developed persistent sexual side effects, are also drinking less alcohol than before.

14 Jun 2013

Pew funds 10 Latin American scientists to conduct research on world's most troubling health problems

Ten scientists were named Pew Latin American Fellows in the Biomedical Sciences by The Pew Charitable Trusts today. The fellowship provides support to advance grantees' research, enables them to study with prominent U.S. scientists, and invests seed capital to help them establish laboratories in their home countries.

14 Jun 2013

Study provides important new resources to advance suicide prevention

A University of British Columbia study sheds important new light on why people attempt suicide and provides the first scientifically tested measure for evaluating the motivations for suicide.

14 Jun 2013

Study provides new insight into how pyrazinamide works

Pyrazinamide (PZA)-a frontline tuberculosis drug-kills dormant persister bacteria and plays a critical role in shortening TB therapy. PZA is used for treating both drug susceptible and multi-drug resistant TB but resistance to PZA occurs frequently and can compromise treatment.

14 Jun 2013

TEDDY study enables scientists to parse genetic mutations associated with type 1 diabetes

Massive samples emanating from a decade-old, international initiative to determine how genetics and environment cause type 1 diabetes are giving scientists a unique perspective on which molecular and environmental factors really contribute to the disease.

14 Jun 2013

Medical Research News

Study demonstrates efficacy of canakinumab at tapering corticosteroid use in patients with SJIA

New drug target may prevent consequences of ACL tear in athletes

Study: Certified bicycle helmets reduce causes of injury and impact force of crash

Farmworkers continue to experience excessive heat even after leaving the fields, shows research

Study suggests promising brain-imaging technique to improve diagnoses of people with movement disorders

CSHL scientists solve the mystery of why some infants born with grave syndrome

Research: Older adults who volunteer for work decrease their risk of hypertension

EULAR announces recipients of Meritorious Service Award

Overweight, obese ERA patients require twice as much drug therapy to achieve successful remission

Study offers hope for development of novel treatments for stroke, neurological diseases

Ischaemic heart disease patients at risk after 1 week of treatment

Novel antibody biomarkers could significantly improve diagnosis in RA, study shows

Findings provide basis for reinvigoration of research efforts in breast cancer prevention

Qiaobing Xu selected as Pew Scholar in Biomedical Sciences

Pew Charitable Trusts selects NYU professor as Pew Scholar in Biomedical Sciences

Finasteride has ability to modulate alcohol intake, finds GW researcher

Pew funds 10 Latin American scientists to conduct research on world's most troubling health problems

Study provides important new resources to advance suicide prevention

Study provides new insight into how pyrazinamide works

TEDDY study enables scientists to parse genetic mutations associated with type 1 diabetes

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Latest News